Amalgamated Bank Alpine Immune Sciences, Inc. Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$17.75 - $41.6 $42,582 - $99,798	-2,399 Reduced 64.89%	1,298 $51,000
Q4 2023 Feb 06, 2024	BUY	$8.54 - $20.22 $350 - $829	41 Added 1.12%	3,697 $70,000
Q2 2023 Aug 11, 2023	BUY	$6.84 - $11.91 $5,629 - $9,801	823 Added 29.05%	3,656 $37,000
Q1 2023 May 02, 2023	BUY	$7.0 - $8.75 $3,136 - $3,920	448 Added 18.78%	2,833 $22,000
Q4 2022 Feb 10, 2023	BUY	$5.45 - $7.35 $1,934 - $2,609	355 Added 17.49%	2,385 $18,000
Q3 2022 Nov 09, 2022	BUY	$6.89 - $9.39 $110 - $150	16 Added 0.79%	2,030 $15,000
Q2 2022 Aug 15, 2022	BUY	$6.71 - $9.52 $825 - $1,170	123 Added 6.5%	2,014 $17,000
Q1 2022 Jun 30, 2022	BUY	$6.41 - $13.89 $12,121 - $26,265	1,891 New	1,891 $17,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.